Table 4.
Longitudinal associations between one-year changes in inflammatory or metabolic markers and tertiles of change in dietary phylloquinone intake (μg/day)
| Tertile 1 | Tertile 2 | p | Tertile 3 | p | p for trend | |
|---|---|---|---|---|---|---|
|
C-Peptide (ng/mL) |
Ref. |
−2.19 (−8.35 to 4.40) |
0.505 |
−6.10 (−12.61 to 0.91) |
0.086 |
0.083 |
|
Ghrelin (pg/mL) |
Ref. |
1.69 (−8.58 to 13.11) |
0.758 |
−15.00 (−24.49 to −4.32) |
0.007 |
0.003 |
|
GIP (pg/mL) |
Ref. |
0.08 (−10.17 to 11.49) |
0.989 |
−12.94 (−22.75 to −1.89) |
0.023 |
0.014 |
|
GLP-1 (ng/mL) |
Ref. |
0.21 (−12.99 to 15.42) |
0.977 |
−17.64 (−29.67 to −3.56) |
0.016 |
0.009 |
|
IL-6 (pg/ml) |
Ref. |
−4.50 (−18.17 to 11.46) |
0.559 |
−27.89 (−39.20 to −14.48) |
<0.001 |
<0.001 |
|
Leptin (ng/mL) |
Ref. |
−7.79 (−15.61 to 0.76) |
0.073 |
−10.26 (−18.62 to −1.03) |
0.030 |
0.044 |
|
PAI-1 (ng/mL) |
Ref. |
−3.06 (−10.65 to 5.17) |
0.454 |
−3.24 (−11.61 to 5.93) |
0.476 |
0.529 |
|
Resistin (ng/mL) |
Ref. |
−2.43 (−11.03 to 7.01) |
0.601 |
−6.66 (−15.71 to 3.35) |
0.184 |
0.180 |
|
TNF (pg/mL) |
Ref. |
−3.96 (−20.47 to 15.98) |
0.674 |
−26.89 (−40.65 to −9.94) |
0.003 |
0.002 |
|
Visfatin (ng/mL) |
Ref. |
−8.08 (−24.73 to 12.24) |
0.408 |
−24.90 (−39.86 to −6.22) |
0.012 |
0.010 |
|
Adiponectin (μg/mL) |
Ref. |
−3.27 (−19.20 to 15.79) |
0.716 |
−7.34 (−23.98 to 12.93) |
0.449 |
0.452 |
| Adipsin (μg/mL) | Ref. | −2.45 (−15.37 to 12.45) | 0.732 | −7.39 (−20.90 to 8.44) | 0.340 | 0.332 |
Multivariable linear regression models were used for analysis. Data are given in % of change (95% IC). Models are adjusted for sex, age, change of body-mass-index, smoking (never, current, past), change of total energy intake (kcal/d), change of fibre intake (g/d), change of dietary polyunsaturated fatty acids intake (g/d), physical activity (kcal/d), intervention group, change of Mediterranean Diet Score (%), T2DM and baseline values of each metabolic marker. GIP Gastric inhibitory polypeptide, GLP-1 Glucagon-like peptide-1, IL-6 Interleukin-6, PAI-1 Plasminogen activator inhibitor-1, TNF, Tumor Necrosis Factor α.